AG
ORMP icon

Algert Global’s Oramed Pharmaceuticals ORMP Stock Holding History

Algert Global’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$65K Buy
19,218
+7,150
+59% +$24.3K ﹤0.01% 1124
2025
Q4 		$34K Buy
+12,068
New +$31.1K ﹤0.01% 1120
2024
Q1 		– Sell
-14,680
Closed -$34K – 1213
2023
Q4 		$34K Hold
14,680
– – ﹤0.01% 1109
2023
Q3 		$38K Buy
+14,680
New +$46.2K ﹤0.01% 1076

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $25B AUM 18.87% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Algert Global's ORMP Position: Q1 2026 in Review

Algert Global increased its Oramed Pharmaceuticals (ORMP) stake by 59% in Q1 2026, buying an estimated $24.3K and bringing the position to 19,218 shares worth $65K. The position accounts for ﹤0.01% of the portfolio, ranked #1124.

Algert Global first reported a position in ORMP in Q3 2023 and has held it in 4 quarters since. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Algert Global held 19,218 shares of Oramed Pharmaceuticals worth $65K as of Q1 2026.
  • Algert Global bought 7,150 Oramed Pharmaceuticals shares in Q1 2026, an estimated $24.3K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Algert Global's portfolio in Q1 2026, its #1124 holding.
  • Algert Global first reported a position in Oramed Pharmaceuticals in Q3 2023 and has held it in 4 quarters since.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Algert Global's 13F filing for Q1 2026, filed 14 May 2026.